Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Cardiology
•
Cardiovascular Imaging
•
Structural Heart Disease
What clinical or echocardiographic parameters do you use to determine the optimal timing for an aortic valve intervention in patients with asymptomatic severe aortic stenosis?
Related Questions
What is your preferred imaging modality for the evaluation of coronary microvascular dysfunction/INOCA and when would you favor it over coronary angiogram with provocative testing?
For asymptomatic, incidentally found Lambl's excrescence, should long-term surveillance imaging be considered and if so, how often should repeat imaging be ordered?
When would you consider using cardiac MRI over nuclear imaging for functional assessment of ischemic heart disease, since it is class IIa indication in the US but otherwise class I in Europe?
Should there be age cut-off considerations when ordering TTEs with bubble routinely as part of stroke work-up?
What is the best way to categorize aortic stenosis in normal LV function with normal LV size, when the peak velocity and mean pressure gradient are in moderate range but AVA shows severe?
What are some TTE findings that suggest worsening function of a bioprosthetic AVR that would require further surveillance or diagnostic imaging?
For a patient with prior bypass graft stenting and severe native vessel disease, would you recommend myocardial perfusion imaging or coronary CTA if there is concern about graft patency?
What is a reasonable imaging modality for older patients with pAfib already on systemic anticoagulation outpatient but presenting with suspected cardioembolic stroke and TTE without evidence of LV thrombus?
In patients with moderate calcific mitral stenosis, possible HFpEF and dyspnea on exertion, how would you differentiate the etiology of the symptoms?
What factors would influence your decision to use or avoid heparin bridging in patients with mechanical heart valves resuming anticoagulation after intracerebral hemorrhage?
